| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:1563-1570.)
© 2007 American Heart Association, Inc.
Heart Failure |
From the Division of Cardiovascular Diseases (K.A.A., M.M.R., J.C.B., R.J.R.) and Division of Epidemiology (S.J.J., D.W.M.), Mayo Clinic and Foundation, Rochester, Minn; and the Department of Medical Informatics (J.A.K.), Erasmus University Medical Center, Rotterdam, the Netherlands.
Correspondence to Khawaja Afzal Ammar, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail ammar.khawaja{at}mayo.edu
Received March 9, 2006; accepted December 18, 2006.
Background Heart failure (HF) is a progressive disorder associated with frequent morbidity and mortality. An American Heart Association/American College of Cardiology staging classification of HF has been developed to emphasize early detection and prevention. The prevalence of HF stages and their association with mortality are unknown. We sought to estimate HF stage prevalence in the community and to measure the association of HF stages with mortality.
Methods and Results A population-based, cross-sectional, random sample of 2029 Olmsted County, Minnesota, residents aged
45 years was identified. Participants were classified by medical record review, symptom questionnaire, physical examination, and echocardiogram as follows: stage 0, healthy; stage A, HF risk factors; stage B, asymptomatic cardiac structural or functional abnormalities; stage C, HF symptoms; and stage D, severe HF. In the cohort, 32% were stage 0, 22% stage A, 34% stage B, 12% stage C, and 0.2% stage D. Mean B-type natriuretic peptide concentrations (in pg/mL) increased by stages: stage 0=26, stage A=32, stage B=53, stage C=137, and stage D=353. Survival at 5 years was 99% in stage 0, 97% in stage A, 96% in stage B, 75% in stage C, and 20% in stage D.
Conclusions The present study provides prevalence estimates and prognostic validation for HF staging in a community cohort. Of note, 56% of adults
45 years of age were classified as being in stage A (risk factors) or B (asymptomatic ventricular dysfunction). HF staging underscores the magnitude of the population at risk for progression to overt HF.
This article has been cited by other articles:
![]() |
M. Jessup MADIT-CRT -- Breathtaking or Time to Catch Our Breath? N. Engl. J. Med., October 1, 2009; 361(14): 1394 - 1396. [Full Text] [PDF] |
||||
![]() |
H. J. Eisen and S. R. Hankins Continuous flow rotary left ventricular assist device: mechanical circulatory support 2.0. J. Am. Coll. Cardiol., July 21, 2009; 54(4): 322 - 324. [Full Text] [PDF] |
||||
![]() |
W. Lieb, V. Xanthakis, L. M. Sullivan, J. Aragam, M. J. Pencina, M. G. Larson, E. J. Benjamin, and R. S. Vasan Longitudinal Tracking of Left Ventricular Mass Over the Adult Life Course: Clinical Correlates of Short- and Long-Term Change in the Framingham Offspring Study Circulation, June 23, 2009; 119(24): 3085 - 3092. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kalogeropoulos, V. Georgiopoulou, S. B. Kritchevsky, B. M. Psaty, N. L. Smith, A. B. Newman, N. Rodondi, S. Satterfield, D. C. Bauer, K. Bibbins-Domingo, et al. Epidemiology of Incident Heart Failure in a Contemporary Elderly Cohort: The Health, Aging, and Body Composition Study Arch Intern Med, April 13, 2009; 169(7): 708 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Baughman and J. A. Jarcho Bridge to Life -- Cardiac Mechanical Support N. Engl. J. Med., August 30, 2007; 357(9): 846 - 849. [Full Text] [PDF] |
||||
![]() |
Prevalence and Prognosis of Heart Failure by ACC/AHA Stage Journal Watch Cardiology, April 18, 2007; 2007(418): 3 - 3. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |